Shay Shemesh
Equibles does not estimate personal net worth.
Get an email with a short summary when Nuvectis Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get NVCT alertsAbout Shay Shemesh
The proxy statement of Nuvectis Pharma, Inc. reports total compensation of $1,586,241 for Shay Shemesh in fiscal 2025, including a base salary of $483,381. Disclosed compensation is on record for 5 fiscal years. Nuvectis Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nuvectis Pharma, Inc. includes Ron Bentsur (CEO and Board Member), James Oliviero (Board Member), Juan Sanchez (Board Member) and 3 others.
Affiliation history
-
Nuvectis Pharma, Inc. (NVCT)
Proxy statement
CurrentStart not stated–present
Last confirmed April 27, 2026
Company network
Leadership on record at Nuvectis Pharma, Inc.
- Ron Bentsur CEO, Board Member
- James Oliviero Board Member
- Juan Sanchez Board Member
- Juan Sanchez, MD Board Member
- Kenneth Hoberman Board Member
- Matthew Kaplan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nuvectis Pharma, Inc. (NVCT) | Chief Development and Operations Officer | $483,381 | $1,586,241 |
| 2024 | Nuvectis Pharma, Inc. (NVCT) | Chief Development & Operations Officer | $468,847 | $1,814,813 |
| 2023 | Nuvectis Pharma, Inc. (NVCT) | Chief Development & Operations Officer | $454,750 | $1,563,400 |
| 2022 | Nuvectis Pharma, Inc. (NVCT) | Chief Development & Operations Officer | $329,268 | $950,468 |
| 2021 | Nuvectis Pharma, Inc. (NVCT) | Chief Development & Operations Officer | $27,083 | $219,139 |
Recent activity
No call appearances or filed executive changes recorded yet.